According to reports from Chris Wheatley, Arsenal is likely to miss the services of their new signing Martin Ordegaad on Sunday as they will be welcoming London rivals Chelsea at the Emirates Stadium.
The 22 year old is reported to have completed his medical today at the London Conley and he is expected to pen down a contract deal which will see him at the Emirates Stadium until June 2026.
The Norwegian international has been signed to increase their creativity at the Gunners' midfield, and a £30 million has been paid to his former club Real Madrid in exchange.
It is reported that the star won't be put under quarantine since he has been double vaccinated against Covid 19, however, he could miss the Sunday match because his Visa has not been granted.
However, Sheffield United stopper Aaron Ramsdale who has agreed on a permanent move to the Emirates Stadium is currently undergoing medical and will be in the squad against Chelsea on Sunday.
Content created and supplied by: London.News (via Opera
News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform
See More
COMMENTS